Loss of the receptors ER, PR and HER2 promotes USP15-dependent stabilization of PARP1 in triple-negative breast cancer-Reference-Cited by-同舟云学术

Loss of the receptors ER, PR and HER2 promotes USP15-dependent stabilization of PARP1 in triple-negative breast cancer

Published:2023-04-03 Issue:5 Volume:4 Page:716-733
ISSN:2662-1347
Container-title:Nature Cancer
language:en
Short-container-title:Nat Cancer

Author:

Sun Xiaoxiang,Tang Huanyin,Chen Yu^ORCID,Chen Zhixi,Hu Zhiyi,Cui Zhen,Tao Yaming,Yuan Jian^ORCID,Fu Yun,Zhuang Zhigang,He Qizhi,Li Qian,Xu Xianghong,Wan Xiaoping,Jiang Ying^ORCID,Mao Zhiyong^ORCID

Funder

National Natural Science Foundation of China

National Key R&D Program of China

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology

Link

https://www.nature.com/articles/s43018-023-00535-w.pdf

Reference59 articles.

1. Bianchini, G., Balko, J. M., Mayer, I. A., Sanders, M. E. & Gianni, L. Triple-negative breast cancer: challenges and opportunities of a heterogeneous disease. Nat. Rev. Clin. Oncol. 13, 674–690 (2016).

2. Sporikova, Z., Koudelakova, V., Trojanec, R. & Hajduch, M. Genetic markers in triple-negative breast cancer. Clin. Breast Cancer 18, e841–e850 (2018).

3. Lyons, T. G. Targeted therapies for triple-negative breast cancer. Curr. Treat. Options Oncol. 20, 82 (2019).

4. Narayan, P., Wahby, S. & Gao, J. J. FDA approval dummary: atezolizumab plus paclitaxel protein-bound for the treatment of patients with advanced or metastatic TNBC whose tumors express PD-L1. Clin. Cancer Res. 26, 2284–2289 (2020).

5. Wang, C. et al. Rational combination therapy for hepatocellular carcinoma with PARP1 and DNA-PK inhibitors. Proc. Natl Acad. Sci. USA 117, 26356–26365 (2020).

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Biomimetic Activation of N‐Nitrosamides with Red Light‐Triggered Nitric Oxide Release via Mediated Electron Transfer;Angewandte Chemie;2024-09-12

2. Biomimetic Activation of N‐Nitrosamides with Red Light‐Triggered Nitric Oxide Release via Mediated Electron Transfer;Angewandte Chemie International Edition;2024-09-12

3. Phase separation of phospho-HDAC6 drives aberrant chromatin architecture in triple-negative breast cancer;Nature Cancer;2024-08-28

4. PRDM1 promotes the ferroptosis and immune escape of thyroid cancer by regulating USP15-mediated SELENBP1 deubiquitination;Journal of Endocrinological Investigation;2024-07-16

5. SOSTDC1 Nuclear Translocation Facilitates BTIC Maintenance and CHD1‐Mediated HR Repair to Promote Tumor Progression and Olaparib Resistance in TNBC;Advanced Science;2024-06-12